These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29962333)

  • 1. Contribution of the Rho-kinase to Systemic Sclerosis and Behçet's Disease.
    Demiryürek S; Baysalman E; Mammadov A; Demiryürek AT
    Curr Pharm Des; 2018; 24(29):3402-3409. PubMed ID: 29962333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
    Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
    Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho Kinases in Autoimmune Diseases.
    Pernis AB; Ricker E; Weng CH; Rozo C; Yi W
    Annu Rev Med; 2016; 67():355-74. PubMed ID: 26768244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Insights into the Roles of Rho Kinase in Cancer.
    Wei L; Surma M; Shi S; Lambert-Cheatham N; Shi J
    Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):259-78. PubMed ID: 26725045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.
    Akhmetshina A; Dees C; Pileckyte M; Szucs G; Spriewald BM; Zwerina J; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2008 Aug; 58(8):2553-64. PubMed ID: 18668558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of systemic sclerosis in patients with Behçet's disease: remission of Behçet's disease in parallel with the progression of skin sclerosis.
    Ichimura Y; Asano Y; Takahashi T; Toyama T; Taniguchi T; Tamaki Z; Isomura S; Miyagaki T; Mitsui H; Sato S
    J Dermatol; 2014 Dec; 41(12):1113-4. PubMed ID: 25389081
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting ROCK signaling in health, malignant and non-malignant diseases.
    Shahbazi R; Baradaran B; Khordadmehr M; Safaei S; Baghbanzadeh A; Jigari F; Ezzati H
    Immunol Lett; 2020 Mar; 219():15-26. PubMed ID: 31904392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Rho-kinase (ROCK2) gene polymorphisms and Behçet's disease.
    Oguz E; Alasehirli B; Pehlivan Y; Onat AM; Oztuzcu S; Ozkara E; Kisacik B; Camci C; Demiryürek AT
    Transl Res; 2012 Dec; 160(6):428-34. PubMed ID: 22939913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet's syndrome.
    Inaloz HS; Evereklioglu C; Unal B; Kirtak N; Eralp A; Inaloz SS
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):56-61. PubMed ID: 14678533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
    Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
    Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNP-mediated binding of TBX1 to the enhancer element of
    Tan H; Su G; Tan X; Qin Y; Chen L; Yuan G; Kijlstra A; Yang P
    Epigenomics; 2021 Oct; 13(19):1523-1537. PubMed ID: 34612069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Rho-kinase inhibitors for cardiovascular medicine.
    Shimokawa H; Rashid M
    Trends Pharmacol Sci; 2007 Jun; 28(6):296-302. PubMed ID: 17482681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of bcl-2 protein in active skin lesions of Behçet's disease.
    Senturk N; Yildiz L; Sullu Y; Kandemir B; Turanli AY
    Int J Dermatol; 2001 Dec; 40(12):747-50. PubMed ID: 11903667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells.
    Takeda Y; Matoba K; Kawanami D; Nagai Y; Akamine T; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of VDR ApaI and TaqI Gene Polymorphisms with the Risk of Scleroderma and Behçet's Disease.
    Kamal A; Gamal SM; Elgengehy FT; Alkemary AK; Siam I
    Immunol Invest; 2016 Aug; 45(6):531-42. PubMed ID: 27409400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-Associated Coiled-Coil Kinase (ROCK) in Molecular Regulation of Angiogenesis.
    Liu J; Wada Y; Katsura M; Tozawa H; Erwin N; Kapron CM; Bao G; Liu J
    Theranostics; 2018; 8(21):6053-6069. PubMed ID: 30613282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho-associated coiled-coil kinase (ROCK) signaling and disease.
    Schofield AV; Bernard O
    Crit Rev Biochem Mol Biol; 2013; 48(4):301-16. PubMed ID: 23601011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behçet's disease: an update on the pathogenesis.
    Gül A
    Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S6-12. PubMed ID: 11760403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ouabain-induced apoptosis and Rho kinase: a novel caspase-2 cleavage site and fragment of Rock-2.
    Ark M; Ozdemir A; Polat B
    Apoptosis; 2010 Dec; 15(12):1494-506. PubMed ID: 20661774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behçet's disease--clinical presentation, diagnostic and therapeutic approach].
    Elbirt D; Asher I; Sthoeger ZM
    Harefuah; 2002 May; 141(5):462-7, 497. PubMed ID: 12073530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.